Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis.
Anolik
J H
JH
Wildy
K
K
Cohn
S E
SE
Marquardt
J D
JD
Totterman
S
S
Zwillich
S H
SH
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000382:microbiology* / Q000473:pathology; D002437:Cefazolin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009287:Naphthyridines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012446:Sacroiliac Joint / Q000382:microbiology* / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification* / Q000472:pathogenicity; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin; D014295:Trimethoprim; D002437:Cefazolin; D013420:Sulfamethoxazole; D012293:Rifampin